Have the number of pulmonary embolism cases increased during the COVID-19 pandemic?

Emine Afşin; Emine Özsari; Suat Konuk; Derya Kocadağ; Emre Bacaksiz

doi:10.5114/fmpcr.2022.115868

eISSN: 2449-8580
ISSN: 1734-3402

Family Medicine & Primary Care Review

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Open access

2/2022
vol. 24

Send email

Copy url:

abstract:

Original paper

Have the number of pulmonary embolism cases increased during the COVID-19 pandemic?

Emine Afşin

¹

,

Emine Özsari

¹

,

Suat Konuk

¹

,

Derya Kocadağ

²

,

Emre Bacaksiz

¹

Department of Chest Diseases, Abant Izzet Baysal University Hospital, Bolu, Turkey
Bolu Provincial Directorate of Health, Bolu, Turkey

Family Medicine & Primary Care Review 2022; 24(2): 111–115

DOI: https://doi.org/10.5114/fmpcr.2022.115868

Online publish date: 2022/06/30

View full text Get citation

PlumX metrics:

Introduction
Coagulation disorders, endothelial dysfunction, immobility and dehydration contribute to deep vein thrombosis (DVT) and pulmonary embolism (PE) in COVID-19 patients. While the prevalence of PE accompanying COVID-19 is high, the number of studies on its long-term effects is limited in literature. Objectives. We expanded this process and aimed to evaluate a one-year period before and during the pandemic. We sought an answer to the question: “Is there a change in the frequency and clinical course of PE?”

Material and methods
Retrospectively, all patients admitted to our pulmonology clinic diagnosed with PE between October 2018–2019 (pre-pandemic) and April 2020–2021 (pandemic period) were included in the study. PE patients hospitalized due to COVID-19 infection were not included in the study.

Results
The prevalence of PE cases increased by 43% in the first year of the pandemic, and there was no significant difference in terms of symptoms, localisation and extent of thrombus in the pulmonary artery, DVT frequency, systolic pulmonary artery pressure (PABs) values, right heart load, frequency of thrombolytic therapy and mortality rates. A significant decrease was observed in predisposing factors of pulmonary embolism only in the postoperative period (7 patients (77.8%) before the pandemic; 2 patients (22.2%) during the pandemic; p = 0.029).

Conclusions
PE cases are encountered more frequently during the pandemic process, and no significant change was seen in patient’s clinical findings and mortality.

keywords:

Have the number of pulmonary embolism cases increased during the COVID-19 pandemic?

Emine Afşin 1 , Emine Özsari 1 , Suat Konuk 1 , Derya Kocadağ 2 , Emre Bacaksiz 1

pulmonary embolism, COVID-19, prognosis

Emine Afşin

¹

,

Emine Özsari

¹

,

Suat Konuk

¹

,

Derya Kocadağ

²

,

Emre Bacaksiz

¹